Related Experiment Videos
[Postpartum hemophilia A with factor VIII inhibitor]
Deutsche Medizinische Wochenschrift (1946)
|May 17, 1985
Summary
A rare acquired hemophilia A (factor VIII inhibitor) developed post-delivery, causing severe bleeding. Treatment with Feiba was effective, and the condition resolved within 16 months, allowing a healthy pregnancy.
Area of Science:
- Hematology
- Obstetrics & Gynecology
- Immunology
Background:
- Acquired hemophilia A, characterized by inhibitors against factor VIII (FVIII), is a rare but life-threatening bleeding disorder.
- Spontaneous development of FVIII inhibitors can occur postpartum, posing significant risks to maternal health.